Two-Year Clinical Trial Findings Show Significant And Persistent Reduction In Blood Pressure With CVRx(R) Rheos(R) Hypertension Therapy

The first available two-year data from the European clinical trial evaluating the Rheos® Hypertension (HT) System were presented at Hypertension Berlin 2008. Developed by U.S.-based CVRx, Inc., the Rheos HT System is the only implantable medical device designed to control hypertension, or high blood pressure. Worldwide, hypertension is a leading and growing cause of heart and kidney disease, stroke and death.

More: continued here

Filed under: Clinical Trials on June 19th, 2008